


Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion
Merck KGaA, Darmstadt, Germany, is reportedly in advanced negotiations to

Illumina Faces Potential $7 Billion Loss from Forced Grail Sale: An Analysis
1. Introduction Background on Illumina and Grail Illumina, Inc. is

Vector Laboratories and Absolute Biotech Announce Merger to Strengthen Life Sciences Capabilities
Vector Laboratories and Absolute Biotech have announced a merger, aiming
